120
Participants
Start Date
August 12, 2025
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Placebo
Single oral dose of matching placebo
K-645 dose level 1
Single oral dose of K-645 dose level 1
K-645 dose level 2
Single oral dose of K-645 dose level 2
RECRUITING
SPRI Clinical Trials, LLC, Brooklyn
RECRUITING
Dent Neurosciences Research Center, Amherst
RECRUITING
Health Research of Hampton Roads, Inc., Newport News
RECRUITING
Peters Medical Research, High Point
RECRUITING
Headache Wellness Center, Greensboro
RECRUITING
Clinical Research Atlanta - Stockbridge, Stockbridge
RECRUITING
DelRicht Research - Atlanta, Atlanta
RECRUITING
Clinical Research Associates, Inc., Nashville
RECRUITING
L-MARC Research Center, Louisville
RECRUITING
Clinical Research Institute, Minneapolis
RECRUITING
Chicago Headache Center and Research Institute, Chicago
RECRUITING
Collective Medical Research, Overland Park
RECRUITING
DelRicht Research - Prairieville, Prairieville
RECRUITING
OK Clinical Research, LLC, Edmond
RECRUITING
DM Clinical Research - Bellaire, Houston
RECRUITING
APD Clinical Research, Splendora
RECRUITING
Albuquerque Clinical Trials, Inc., Albuquerque
RECRUITING
Excell Research, Inc., Oceanside
Lead Sponsor
Kallyope Inc.
INDUSTRY